Apolipoprotein M is required for preβ-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis

被引:0
|
作者
Christian Wolfrum
Matthew N Poy
Markus Stoffel
机构
[1] The Laboratory of Metabolic Diseases,
[2] The Rockefeller University,undefined
来源
Nature Medicine | 2005年 / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
High-density lipoproteins (HDLs) are considered antiatherogenic because they mediate reverse cholesterol transport from the periphery to the liver for excretion and degradation. Here we show that mice deficient in apolipoprotein M (apoM), a component of the HDL particle, accumulated cholesterol in large HDL particles (HDL1) while the conversion of HDL to preβ-HDL was impaired. Accordingly, apoM-deficient mice lacked preβ-HDL, a subclass of lipid-poor apolipoproteins that serves as a key acceptor of peripheral cellular cholesterol. This deficiency led to a markedly reduced cholesterol efflux from macrophages to apoM-deficient HDL compared to normal HDL in vitro. Overexpression of apoM in Ldlr−/− mice protected against atherosclerosis when the mice were challenged with a cholesterol-enriched diet, showing that apoM is important for the formation of preβ-HDL and cholesterol efflux to HDL, and thereby inhibits formation of atherosclerotic lesions.
引用
收藏
页码:418 / 422
页数:4
相关论文
共 50 条
  • [31] Influence of SAA on cellular cholesterol efflux to HDL
    Cai, L
    Wei, S
    de Beer, MC
    de Beer, FC
    van der Westhuyzen, DR
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A77 - A77
  • [32] Tweaking the cholesterol efflux capacity of reconstituted HDL
    Ma, Cheng-I J.
    Beckstead, Jennifer A.
    Thompson, Airlia
    Hafiane, Anouar
    Wang, Rui Hao Leo
    Ryan, Robert O.
    Kiss, Robert S.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2012, 90 (05): : 636 - 645
  • [33] HDL CHOLESTEROL EFFLUX CAPACITY AND CARDIOVASCULAR MORTALITY
    Ritsch, A.
    Duerr, A.
    Kahler, P.
    Stojakovic, T.
    Silbernagel, G.
    Scharnagl, H.
    Kleber, M. E.
    Maerz, W.
    ATHEROSCLEROSIS, 2015, 241 (01) : E28 - E28
  • [34] Apolipoprotein A-II, HDL metabolism and atherosclerosis
    Tailleux, A
    Duriez, P
    Fruchart, JC
    Clavey, V
    ATHEROSCLEROSIS, 2002, 164 (01) : 1 - 13
  • [35] Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis
    Ormseth, Michelle J.
    Yancey, Patricia G.
    Yamamoto, Suguru
    Oeser, Annette M.
    Gebretsadik, Tebeb
    Shintani, Ayumi
    Linton, MacRae F.
    Fazio, Sergio
    Davies, Sean S.
    Roberts, L. Jackson, II
    Vickers, Kasey C.
    Raggi, Paolo
    Kon, Valentina
    Stein, C. Michael
    IJC METABOLIC & ENDOCRINE, 2016, 13 : 6 - 11
  • [36] Characterization of phospholipids in pre-α HDL:: Selective phospholipid efflux with apolipoprotein A-I
    Zhang, WW
    Asztalos, B
    Roheim, PS
    Wong, L
    JOURNAL OF LIPID RESEARCH, 1998, 39 (08) : 1601 - 1607
  • [37] Glucocorticoids impair HDL-mediated cholesterol efflux but paradoxically increase HDL-cholesterol concentration
    Bouillet, B.
    Gautier, T.
    Denimal, D.
    Samson, M.
    Masson, D.
    de Barros, J. -P. Pais
    Maquart, G.
    Xolin, M.
    Dalle, H.
    Grosfeld, A.
    Moldes, M.
    Feve, B.
    Verges, B.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S251 - S251
  • [38] Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres Effects of HDL Particle Remodeling on Cholesterol Efflux
    Navdaev, Alexei V.
    Sborgi, Lorenzo
    Wright, Samuel D.
    Didichenko, Svetlana A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (05) : 1182 - 1194
  • [39] Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux
    Lee, M
    Kovanen, PT
    Tedeschi, G
    Oungre, E
    Franceschini, G
    Calabresi, L
    JOURNAL OF LIPID RESEARCH, 2003, 44 (03) : 539 - 546
  • [40] Role of Hyaluronic Acid on Apolipoprotein A1 and HDL-Mediated Cholesterol Efflux in Macrophages
    Matsuki, Kota
    Ogura, Masatsune
    Harada-Shiba, Mariko
    DIABETES, 2018, 67